- Home
- BOF vs VRCA Comparison
BOF vs VRCA Comparison
Compare BOF & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- VRCA
- Stock Information
- Founded
- BOF 2017
- VRCA 2013
- Country
- BOF United States
- VRCA United States
- Employees
- BOF N/A
- VRCA N/A
- Industry
- BOF Packaged Foods
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- BOF Consumer Staples
- VRCA Health Care
- Exchange
- BOF Nasdaq
- VRCA Nasdaq
- Market Cap
- BOF 33.2M
- VRCA 32.7M
- IPO Year
- BOF 2023
- VRCA 2018
- Fundamental
- Price
- BOF $3.00
- VRCA $6.44
- Analyst Decision
- BOF
- VRCA Hold
- Analyst Count
- BOF 0
- VRCA 2
- Target Price
- BOF N/A
- VRCA N/A
- AVG Volume (30 Days)
- BOF 182.7K
- VRCA 169.4K
- Earning Date
- BOF 11-12-2025
- VRCA 11-14-2025
- Dividend Yield
- BOF N/A
- VRCA N/A
- EPS Growth
- BOF N/A
- VRCA N/A
- EPS
- BOF N/A
- VRCA N/A
- Revenue
- BOF $11,218,127.00
- VRCA $30,829,000.00
- Revenue This Year
- BOF N/A
- VRCA $332.45
- Revenue Next Year
- BOF N/A
- VRCA $12.85
- P/E Ratio
- BOF N/A
- VRCA N/A
- Revenue Growth
- BOF 72.85
- VRCA 234.73
- 52 Week Low
- BOF $1.53
- VRCA $3.28
- 52 Week High
- BOF $3.44
- VRCA $13.60
- Technical
- Relative Strength Index (RSI)
- BOF 55.60
- VRCA 78.05
- Support Level
- BOF $2.55
- VRCA $3.90
- Resistance Level
- BOF $3.00
- VRCA $4.64
- Average True Range (ATR)
- BOF 0.25
- VRCA 0.47
- MACD
- BOF -0.05
- VRCA 0.28
- Stochastic Oscillator
- BOF 48.39
- VRCA 100.00
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.